Indivior Pharmaceuticals Inc
- INDV
- NASDAQ
- Drug Manufacturers - Specialty & Generic
- Opioid Dependence Treatment
- Addiction Medicine
- Buprenorphine-based Drugs
$34.26
Today +1.15%Quote Oct 20, 2026, 02:09 PM UTC
−2.90%over the last month
Max drawdown −12.0%From 1-month high −8.2%3 months −16.3%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
About Indivior Pharmaceuticals
Indivior Pharmaceuticals Inc. operates as a holding company, primarily engaged in the research, production, and distribution of buprenorphine-based prescription medications designed to treat opioid dependence. Its product lineup features key pharmaceuticals such as Suboxone Film, Suboxone Tablet, and Subutex Tablet.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
NASDAQ
Employees
833
Dividend date
Nov 6, 2026
Market value
$4.27B
Quote Oct 20
Floor
$33.69
1.7% below price
Resistance
$34.96
2.0% above price
Price vs analyst targets
4 analysts
Lowest target
$43.00Highest target
$53.00
$43.00Highest target
$53.00
- Price $34.26
- Average target $48.00
- Analysts' target range
The price is below even the lowest analyst target. Analysts' average target sits about 40% higher.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about INDVPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free